Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

782 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical features and outcomes of 35 disseminated intravascular coagulation cases treated with recombinant human soluble thrombomodulin at a single institution.
Kawano N, Yoshida S, Ono N, Himeji D, Nagahiro Y, Sayaka Kawano, Yamashita K, Ikeda N, Uezono S, Ochiai H, Kawano F, Kikuchi I, Ishikawa F, Shimoda K, Ueda A, Akashi K. Kawano N, et al. Among authors: ochiai h. J Clin Exp Hematop. 2011;51(2):101-7. doi: 10.3960/jslrt.51.101. J Clin Exp Hematop. 2011. PMID: 22104308 Free article.
Clinical features and treatment outcomes of six patients with disseminated intravascular coagulation resulting from acute promyelocytic leukemia and treated with recombinant human soluble thrombomodulin at a single institution.
Kawano N, Kuriyama T, Yoshida S, Yamashita K, Ochiai H, Nakazaki S, Tasaki A, Ueda A. Kawano N, et al. Among authors: ochiai h. Intern Med. 2013;52(1):55-62. doi: 10.2169/internalmedicine.52.7978. Epub 2013 Jan 1. Intern Med. 2013. PMID: 23291674 Free article.
Effects of recombinant human soluble thrombomodulin treatment for disseminated intravascular coagulation at a single institution--an analysis of 62 cases caused by infectious diseases and 30 cases caused by hematological diseases.
Kawano N, Tasaki A, Kuriyama T, Tahara Y, Yoshida S, Ono N, Himeji D, Yamashita K, Shibata Y, Goto T, Inoue T, Yokota-Ikeda N, Uezono S, Yuge A, Nishiguchi T, Kinjo T, Ogura Y, Beppu K, Ueda Y, Kinoshita M, Moritake H, Shimoda K, Ochiai H, Ueda A. Kawano N, et al. Among authors: ochiai h. Intern Med. 2014;53(3):205-13. doi: 10.2169/internalmedicine.53.0715. Intern Med. 2014. PMID: 24492688 Free article.
782 results